Melanocortin receptors: new opportunities in drug discovery

被引:57
作者
Wikberg, JES [1 ]
机构
[1] Uppsala Univ, Div Pharmacol, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden
关键词
agouti; agouti related peptide; feeding control; melanocortin receptors; melanocyte stimulating hormone; organic compounds; peptide agonists; peptide antagonists; physiological mechanisms; pro-opio melanocortins; therapeutic utility;
D O I
10.1517/13543776.11.1.61
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The cloning of five different subtypes of melanocortin receptors, MC1-5. have provided new opportunities for the discovery of drugs that may be useful for the treatment of a variety Of clinically important conditions, including MC1 receptor agonists for inflammatory diseases, MC3 receptor-agonists for sexual dysfunctions and MC4 receptor agonists and antagonists for treatment of obesity, anorexia and drug abuse. This review discusses patents covering the cloning of the MC receptors, the endogenous MC receptor antagonists agouti signalling peptide and agouti related protein and novel compounds target towards the MC receptors.
引用
收藏
页码:61 / 76
页数:16
相关论文
共 84 条
[41]   AGOUTI PROTEIN IS AN ANTAGONIST OF THE MELANOCYTE-STIMULATING-HORMONE RECEPTOR [J].
LU, DS ;
WILLARD, D ;
PATEL, IR ;
KADWELL, S ;
OVERTON, L ;
KOST, T ;
LUTHER, M ;
CHEN, WB ;
WOYCHIK, RP ;
WILKISON, WO ;
CONE, RD .
NATURE, 1994, 371 (6500) :799-802
[42]   Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides [J].
Marsh, DJ ;
Hollopeter, G ;
Huszar, D ;
Laufer, R ;
Yagaloff, KA ;
Fisher, SL ;
Burn, P ;
Palmiter, RD .
NATURE GENETICS, 1999, 21 (01) :119-122
[43]  
MELACURE THER, 1994, Patent No. 9404674
[44]  
MELACURE THERAPEUTIC, 1999, Patent No. 9947148
[45]  
MELACURE THERAPEUTIC, 1998, Patent No. 9837097
[46]  
MELACURE THERAPEUTIC, 2000, Patent No. 035952
[47]  
MERCK CO, 2000, Patent No. 0028002
[48]  
MERCK CO, 1999, Patent No. 9955832
[49]  
MERCK CO, 2000, Patent No. 9964002
[50]  
MERCK CO, 2000, Patent No. 0027863